| 000 | 01470 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515195844.0 | ||
| 264 | 0 | _c20100203 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1528-4336 | ||
| 024 | 7 |
_a10.1310/hct1005-306 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDragovic, G J | |
| 245 | 0 | 0 |
_aComparison of nucleoside reverse transcriptase inhibitor use as part of first-line therapy in a Serbian and a UK HIV clinic. _h[electronic resource] |
| 260 |
_bHIV clinical trials _c |
||
| 300 |
_a306-13 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDidanosine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHospitals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aSerbia |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 |
_aStavudine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aSmith, C J | |
| 700 | 1 | _aJevtovic, D J | |
| 700 | 1 | _aJohnson, M A | |
| 700 | 1 | _aRanin, J | |
| 700 | 1 | _aSalemovic, D | |
| 700 | 1 | _aYoule, M S | |
| 773 | 0 |
_tHIV clinical trials _gvol. 10 _gno. 5 _gp. 306-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1310/hct1005-306 _zAvailable from publisher's website |
| 999 |
_c19348120 _d19348120 |
||